Vinati Organics Limited (BOM:524200)
India · Delayed Price · Currency is INR | Market Cap | 142.59B -18.9% |
| Revenue (ttm) | 22.71B +5.6% |
| Net Income | 4.43B +14.6% |
| EPS | 42.73 +14.7% |
| Shares Out | 103.67M |
| PE Ratio | 32.19 |
| Forward PE | 27.60 |
| Dividend | 7.50 (0.54%) |
| Ex-Dividend Date | Sep 19, 2025 |
| Volume | 3,356 |
| Average Volume | 6,058 |
| Open | 1,414.35 |
| Previous Close | 1,376.30 |
| Day's Range | 1,358.00 - 1,414.40 |
| 52-Week Range | 1,370.00 - 2,039.70 |
| Beta | 0.18 |
| RSI | 25.52 |
| Earnings Date | May 15, 2026 |
About Vinati Organics
Vinati Organics Limited manufactures and sells specialty organic intermediaries and monomers in India and internationally. The company offers specialty monomers comprising 2-acrylamido 2-methylpropane sulphonic acid, sodium salt of 2-acrylamido-2-methylpropane sulphonic acid, N-tertiary butyl acrylamide, and N-tertiary octyl acrylamide. It also provides specialty aromatics, including iso butyl benzene used as a basic raw material in the pharmaceutical and perfume industries; normal butyl benzene that is used in the production of N-aryl azoles; ... [Read more]
Financial Performance
In fiscal year 2025, Vinati Organics's revenue was 22.48 billion, an increase of 18.33% compared to the previous year's 19.00 billion. Earnings were 4.05 billion, an increase of 25.47%.
Financial StatementsNews
Stocks to buy today on February 4: Citi expects 52.6% upside in LIC Housing, Jefferies sees 49.3% in ONGC, MOSL projects 48.7% in Vinati Organics
On February 4, leading brokerages highlighted their top stock picks, offering strong upside potential for investors. Here’s a summary of the positively rated stocks along with their current market pri...
Vinati Organics Q3FY25 results: Revenue rises 16.5% YoY to Rs 521.68 crore, net profit up 21.7% to Rs 93.58 crore
The company maintained a strong earnings per share (EPS), with basic and diluted EPS at ₹9.04 for Q3FY25, compared to ₹7.42 in Q3FY24.